-
Forward Look
Orphan Drugs Still Find a HomeThirty years on, landmark federal legislation continues to benefit patients with rare cancers.
by Emily Gertz
-
Survivor Profile
Macho ManCarlos De La Cuesta is redefining manhood after prostate cancer.
by Jocelyn Selim
-
Yesterday & Today
The Amazing RideSally Ride's life was cut short by pancreatic cancer. But as the first American woman in space, she still inspires girls to pursue careers in science–and reach for the stars.
by Alexandra Goho
-
Q&A
The Legacy of Henrietta LacksAuthor Rebecca Skloot reflects on the contributions of one woman to science and the importance of informed consent in human research.
by Alexandra Goho
-
Forward Look
Confronting Lung Cancer StigmaAn ad campaign shines a light on lung cancer blame.
by Yvonne Lee
-
First Person
Keeping Sight of HopeA survivor keeps an eye on what's ahead after a rare cancer diagnosis.
by Sue Russell
-
Survivor Profile
Let’s TalkDrawing on her own struggle with the emotional pain of a cancer diagnosis and treatment, Lee Miller empowers other patients to effectively communicate with their doctors.
by Jenny Song
-
Yesterday & Today
The Sex Machine vs. Prostate CancerEven cancer couldn't slow down James Brown.
by Jocelyn Selim
-
Survivor Profile
Patients’ Rights PowerhouseMyra Christopher wages a personal battle with a rare cancer while continuing to passionately advocate for patients.
by Charlotte Huff
-
Forward Look
Diagnosis: DebtEven for the insured, cancer care can be a financial burden.
by Jocelyn Selim
Legislation to speed cancer drug development for children and adolescents requires drug companies to test drugs in children, but trials in people under 18 may take years to generate results.
by Marci A. Landsmann
Understanding Stress and CancerA symposium at the AACR Annual Meeting explores how social factors contribute to elevated risk of cancer in some populations.
by Eric Fitzsimmons
Exploring Amino Acids’ Impact on Tumor GrowthResearchers are investigating how to match specific dietary changes with therapy to impede cancer progression.
by Thomas Celona
Study Shows Minority Participation in Clinical Trials May Be DecliningResearcher speculates that costly genetic testing may be limiting outreach to underserved communities.
by Marci A. Landsmann
-
Using Lymphocytes to Attack TumorsSooner rather than later may be the best strategy for using an experimental treatment for advanced melanoma.
-
Closing Disparities Through Genetic TestingOlufunmilayo Olopade seeks widespread use of testing to encourage prevention and early detection of deadly cancers.
Learning Medicare’s ABCDs
